Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35a pseudogene 36 (RPL35AP36) is a human pseudogene related to the functional ribosomal protein L35a gene. Pseudogenes are non-coding segments of DNA that resemble protein-coding genes but lack the ability to be transcribed into functional proteins due to accumulated mutations and alterations in their sequence. RPL35AP36 is therefore not believed to be expressed as a protein or to play a direct biological or disease-related role. It is one of numerous processed pseudogenes related to ribosomal protein genes, and no evidence currently supports its function as a therapeutic target. RPL35AP36 is classified as a pseudogene, denoted by the "P" in the abbreviation. It is related to the ribosomal protein L35a gene (RPL35A), which is protein-coding and essential for ribosome function, but RPL35AP36 itself is not protein-coding and is not known to produce a functional protein product. There are no reported interacting drugs, roles in disease, or therapeutic applications for this pseudogene. It does not act as a receptor, enzyme, transporter, or other conventional drug target class. Pseudogenes are commonly used as genomic markers or for evolutionary studies but are not considered targets for drug therapy or biomarker use in clinical settings. There is no misspelling or major error in the name or identification of this gene based on appropriate databases, but it is important not to confuse it with its protein-coding homolog RPL35A.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 36 (RPL35AP36).